Exact Mass: 676.6158

Exact Mass Matches: 676.6158

Found 26 metabolites which its exact mass value is equals to given mass value 676.6158, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

CE(20:2(6Z,9Z))

(2R,5S,15R)-2,15-Dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl (11Z,14Z)-icosa-11,14-dienoic acid

C47H80O2 (676.6158)


Lactosylceramide (d18:1/16:0) is a lactosylceramide or LacCer. Lactosylceramides are the most important and abundant of the diosylceramides. Lactosylceramides (LacCer) were originally called cytolipin H. It is found in small amounts only in most animal tissues, but it has a number of significant biological functions and it is of great importance as the biosynthetic precursor of most of the neutral oligoglycosylceramides, sulfatides and gangliosides. In animal tissues, biosynthesis of lactosylceramide involves addition of the second monosaccharides unit (galactose) as its nucleotide derivative to monoglucosylceramide, catalysed by a specific beta-1,4-galactosyltransferase on the lumenal side of the Golgi apparatus. The glucosylceramide precursor must first cross from the cytosolic side of the membrane, possibly via the action of a flippase. The lactosylceramide produced can be further glycosylated or transferred to the plasma membrane. Lactosylceramide may assist in stabilizing the plasma membrane and activating receptor molecules in the special micro-domains or rafts, as with the cerebrosides. It may also have its own specialized function in the immunological system in that it is known to bind to specific bacteria. In addition, it is believed that a number of pro-inflammatory factors activate lactosylceramide synthase to generate lactosylceramide, which in turn activates "oxygen-sensitive" signalling pathways that affect such cellular processes as proliferation, adhesion, migration and angiogenesis. Dysfunctions in these pathways can affect several diseases of the cardiovascular system, cancer and inflammatory states, so lactosylceramide metabolism is a potential target for new therapeutic treatments. beta-D-Galactosyl-1,4-beta-D-glucosylceramide is the second to last step in the synthesis of N-Acylsphingosine and is converted Cholesteryl eicosadienoic acid is a cholesteryl ester. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). Cholesteryl eicosadienoic acid has been found in triglycerides-rich cells such as monocyte-derived macrophages. (PMID: 9162758).

   

cholest-5-en-3beta-yl (11Z,14Z-eicosadienoate)

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (11Z,14Z)-icosa-11,14-dienoate

C47H80O2 (676.6158)


cholest-5-en-3beta-yl (11Z,14Z-eicosadienoate) is classified as a member of the Cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. cholest-5-en-3beta-yl (11Z,14Z-eicosadienoate) is considered to be practically insoluble (in water) and basic. cholest-5-en-3beta-yl (11Z,14Z-eicosadienoate) is a sterol lipid molecule

   

Ceragenin CSA-13

N-[4-[3,7,12-tris(3-aminopropoxy)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentyl]octan-1-amine

C41H80N4O3 (676.623)


   

beta-sitosterol linoleate|beta-sitosteryl linoleate

beta-sitosterol linoleate|beta-sitosteryl linoleate

C47H80O2 (676.6158)


   

(24S)-24-Ethyl-5,22,25-cholestatrien-3beta-yl-stearat

(24S)-24-Ethyl-5,22,25-cholestatrien-3beta-yl-stearat

C47H80O2 (676.6158)


   

18:1 Stigmasteryl ester

Stigmast-5,22E-dien-3beta-yl (9Z-octadecenoate)

C47H80O2 (676.6158)


   

18:2 Sitosteryl ester

Stigmast-5-en-3beta-yl (9Z,12Z-octadecadienoate)

C47H80O2 (676.6158)


   

CE(20:2)

cholest-5-en-3beta-yl (11Z,14Z-eicosadienoate)

C47H80O2 (676.6158)


   

Cholesteryl eicosadienoate

Cholest-5-en-3-ol(3b)-11,14-eicosadienoic acid

C47H80O2 (676.6158)


   

CE 20:2

cholest-5-en-3beta-yl (11Z,14Z-eicosadienoate)

C47H80O2 (676.6158)


   

18:1 Stigmasterol ester

Stigmast-5,22E-dien-3beta-yl (9Z-octadecenoate)

C47H80O2 (676.6158)


   

18:2 Sitosterol ester

Stigmast-5-en-3beta-yl (9Z,12Z-octadecadienoate)

C47H80O2 (676.6158)


   

Stigmasteryl oleate

Stigmasteryl oleate

C47H80O2 (676.6158)


   

β-Sitosteryl linoleate

β-Sitosteryl linoleate

C47H80O2 (676.6158)


   

Cholest-5-en-3beta-ol, 11,14-eicosadienoate

Cholest-5-en-3beta-ol, 11,14-eicosadienoate

C47H80O2 (676.6158)


   

[17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (10E,12E)-octadeca-10,12-dienoate

[17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (10E,12E)-octadeca-10,12-dienoate

C47H80O2 (676.6158)


   

[17-[(E)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (Z)-octadec-11-enoate

[17-[(E)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (Z)-octadec-11-enoate

C47H80O2 (676.6158)


   

[17-[(E)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-nonadec-9-enoate

[17-[(E)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-nonadec-9-enoate

C47H80O2 (676.6158)


   

[17-(5,6-dimethylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (7E,9E)-nonadeca-7,9-dienoate

[17-(5,6-dimethylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (7E,9E)-nonadeca-7,9-dienoate

C47H80O2 (676.6158)


   

[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (11Z,14Z)-icosa-11,14-dienoate

[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (11Z,14Z)-icosa-11,14-dienoate

C47H80O2 (676.6158)


   

cholest-5-en-3beta-yl (11Z,14Z-eicosadienoate)

cholest-5-en-3beta-yl (11Z,14Z-eicosadienoate)

C47H80O2 (676.6158)


   

CE(20:2(6Z,9Z))

CE(20:2(6Z,9Z))

C47H80O2 (676.6158)


   

SiE(18:2)

SiE(18:2)

C47H80O2 (676.6158)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

ChE(20:2)

ChE(20:2)

C47H80O2 (676.6158)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

ZyE(20:1)

ZyE(20:1)

C47H80O2 (676.6158)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Sitosterol Ester 18:2

Sitosterol Ester 18:2

C47H80O2 (676.6158)